N(6)-methyladenosine modification of ADGRA3 by ZC3H13 suppresses papillary thyroid cancer cell malignancy by inactivating the PI3K/Akt/mTOR signaling pathway
{{output}}
Background: N(6)-methyladenosine (m6A) modification is a posttranscriptional regulatory mechanism involved in tumorigenesis. Adhesion G protein-coupled receptor A3 (ADGRA3) has been implicated in various biological processes; how... ...
